Summary of opinion: Obiltoxaximab SFL,obiltoxaximab, 17/09/2020, Positive
Summary of opinion: Obiltoxaximab SFL,obiltoxaximab, 17/09/2020, Positive
Italiano
Summary of opinion: Obiltoxaximab SFL,obiltoxaximab, 17/09/2020, Positive
Summary of opinion: Lynparza,olaparib, 17/09/2020, Positive
Summary of opinion: Orfadin,nitisinone, 17/09/2020, Positive
Summary of opinion: Zavicefta,ceftazidime / avibactam, 17/09/2020, Positive
Summary of opinion: Deltyba,delamanid, 17/09/2020, Positive
Summary of opinion: Rivaroxaban Accord,rivaroxaban, 17/09/2020, Positive
Summary of opinion: Nyvepria,pegfilgrastim, 17/09/2020, Positive
Summary of opinion: Symkevi,tezacaftor / ivacaftor, 17/09/2020, Positive
Summary of opinion: Phelinun,melphalan, 17/09/2020, Positive
Summary of opinion: Flucelvax Tetra,influenza vaccine surface antigen inactivated prepared in cell cultures, 17/09/2020, Positive
80.211.154.110